- Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
Clinical trials
-
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke -
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke - Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
-
The TwoPlus Study-Comparative Effectiveness of an Individualized Model of Hemodialysis vs. Conventional Hemodialysis - Investigator
- Alaa S Awad
- Ages
- 18 Years - N/A
- Sexes
- All
-
BCG in combination with durvalumab in adult BCG-naive, high-risk NMIBC participants - Investigator
- Kethandapatti Balaji
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
E3: Examining the personal External Exposome among children with asthma - Investigator
- Jennifer N Fishe
- Ages
- 10 Years - 17 Years
- Sexes
- All
-
DAPA-HF ACT - Investigator
- Francesco Franchi
- Ages
- 18 Years - N/A
- Sexes
- All
-
Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY) - Investigator
- Michael D Schweitzer Barrios
- Ages
- 40 Years - 80 Years
- Sexes
- All